OPKO Health
OPK
#5857
Rank
HK$8.28 B
Marketcap
HK$10.43
Share price
-0.74%
Change (1 day)
-14.62%
Change (1 year)

OPKO Health (OPK) - Total debt

Total debt on the balance sheet as of September 2025 : HK$3.07 Billion

According to OPKO Health 's latest financial reports the company's total debt is HK$3.07 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

OPKO Health - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$3.91 B53.55%
2023-12-31HK$2.55 B6.83%
2022-12-31HK$2.38 B20.18%
2021-12-31HK$1.98 B-13.01%
2020-12-31HK$2.28 B-7.2%
2019-12-31HK$2.46 B47.21%
2018-12-31HK$1.67 B35.42%
2017-12-31HK$1.23 B50.95%
2016-12-31HK$0.81 B-29.54%
2015-12-31HK$1.16 B1.55%
2014-12-31HK$1.14 B-35.29%
2013-12-31HK$1.76 B904.75%
2012-12-31HK$0.17 B158.42%
2011-12-31HK$68.01 M-40.51%
2010-12-31HK$0.11 B-25.01%
2009-12-31HK$0.15 B43.06%
2008-12-31HK$0.10 B-3.99%
2007-12-31HK$0.11 B
2002-12-31HK$1.57 M0.01%
2001-12-31HK$1.57 M61.56%
2000-12-31HK$0.97 M-7.04%
1999-12-31HK$1.04 M-32.31%
1998-12-31HK$1.54 M99.95%
1997-12-31HK$0.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$356.49 B 11,481.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$100.74 B 3,172.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$21.06 B 584.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.90 B 4,217.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
HK$10.18 B 230.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.33 B 12,808.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$50.83 B 1,551.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$1.61 B-47.50%๐Ÿ‡บ๐Ÿ‡ธ USA